
Newsroom
Artemis DNA
About
<p>Artemis DNA is a full service, Clinical Laboratory Improvement Amendments (CLIA) certified, College of American Pathologists (CAP) accredited, high-complexity clinical diagnostic laboratory company that provides proprietary Next Generation Sequencing (NGS) genetic testing and diagnostic laboratory services for a wide variety of medical specialties, including cardiology, oncology, immunology, neurology, reproductive health and pharmacogenomics.</p> <p>Artemis DNA’s testing enhances the delivery of “personalized medicine” by assessing a patient’s own genetic makeup and clinical characteristics which allows for informed decision making in prevention and treatment choices. Artemis DNA also provides pre- and post-testing genetic education and counseling services, as well as conducting research and development to discover and develop additional novel diagnostic services. Artemis DNA is headquartered in Irvine, California. For more information, visit https://www.artemisdna.com.</p>
Press Releases
Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California
Released on June 15, 2022
Artemis DNA Forays Into Multi-Billion Dollar Cancer Liquid Biopsy Market
Released on June 6, 2022
Artemis DNA Announces Global Expansion, Begins Offering Genetic Testing and Early Detection of Cancer Technology to Vietnam
Released on April 11, 2022
Newsroom powered by PR Underground.